Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons

Journal of Neuroscience Methods

Volumn 205, Issue 1, 2012, Pages 139-147

  Peviani, Marco ^a   Kurosaki, Mami ^a   Terao, Mineko ^a   Lidonnici, Dario ^a   Gensano, Francesco ^a   Battaglia, Elisa ^a   Tortarolo, Massimo ^a   Piva, Roberto ^b   Bendotti, Caterina ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cell targeting; Motor neurons; Promoters; Viral vectors

Indexed keywords

LENTIVIRUS VECTOR; RECOMBINANT LENTIVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HOMEOBOX; HOMEOBOX HB9; IN VIVO STUDY; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANIMALS; ANTERIOR HORN CELLS; ASTROCYTES; CHOLINE O-ACETYLTRANSFERASE; COCULTURE TECHNIQUES; FEMALE; FLUORESCENT DYES; GENE THERAPY; GENETIC MARKERS; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; LENTIVIRUS; MICE; MICE, INBRED C57BL; MOTOR NEURONS; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSGENES;

EID: 84856064875     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.12.024     Document Type: Article

References (40)

1. Abdellatif A.A., Pelt J.L., Benton R.L., Howard R.M., Tsoulfas P., Ping P., et al. Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems. J Neurosci Res 2006, 84:553-567.
2. Abordo-Adesida E., Follenzi A., Barcia C., Sciascia S., Castro M.G., Naldini L., et al. Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum Gene Ther 2005, 16:741-751.
3. Arber S., Han B., Mendelsohn M., Smith M., Jessell T.M., Sockanathan S. Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 1999, 23:659-674.
4. Azzouz M., Mazarakis N. Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases. Curr Gene Ther 2004, 4:277-286.
5. Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S.M., et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004, 429:413-417.
6. Blesch A. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer. Methods 2004, 33:164-172.
7. Brown B.D., Gentner B., Cantore A., Colleoni S., Amendola M., Zingale A., et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007, 25:1457-1467.
8. Brown B.D., Venneri M.A., Zingale A., Sergi Sergi L., Naldini L. Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat Med 2006, 12:585-591.
9. Buning H., Perabo L., Coutelle O., Quadt-Humme S., Hallek M. Recent developments in adeno-associated virus vector technology. J Gene Med 2008, 10:717-733.
10. Chang Q., Martin L.J. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 2011, 31(8):2815-2827.
11. Coffin J.M.H., Stephen H., Varmus, Harold E. Retroviruses 1997, Cold Spring Harbor Laboratory Press, Plainview (NY).
12. de Carvalho M., Swash M. Amyotrophic lateral sclerosis: an update. Curr Opin Neurol 2011, 24:497-503.
13. De Vos K.J., Grierson A.J., Ackerley S., Miller C.C. Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 2008, 31:151-173.
14. Ezzi S.A., Lariviere R., Urushitani M., Julien J.P. Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS. J Neurochem 2010, 115:1102-1111.
15. Guillot S., Azzouz M., Deglon N., Zurn A., Aebischer P. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic mice. Neurobiol Dis 2004, 16:139-149.
16. Hendriks W.T., Eggers R., Verhaagen J., Boer G.J. Gene transfer to the spinal cord neural scar with lentiviral vectors: predominant transgene expression in astrocytes but not in meningeal cells. J Neurosci Res 2007, 85:3041-3052.
17. Hester M.E., Foust K.D., Kaspar R.W., Kaspar B.K. AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALS. Curr Gene Ther 2009, 9:428-433.
18. Hirasawa M., Cho A., Sreenath T., Sauer B., Julien J.P., Kulkarni A.B. Neuron-specific expression of Cre recombinase during the late phase of brain development. Neurosci Res 2001, 40:125-132.
19. Jaarsma D., Teuling E., Haasdijk E.D., De Zeeuw C.I., Hoogenraad C.C. Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. J Neurosci 2008, 28:2075-2088.
20. Jakobsson J., Ericson C., Jansson M., Bjork E., Lundberg C. Targeted transgene expression in rat brain using lentiviral vectors. J Neurosci Res 2003, 73:876-885.
21. Jakobsson J., Nielsen T.T., Staflin K., Georgievska B., Lundberg C. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors. Gene Ther 2006, 13:966-973.
22. Keller A.F., Gravel M., Kriz J. Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells. Glia 2009, 57:1130-1142.
23. Kumar P., Woon-Khiong C. Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications. Curr Gene Ther 2011, 11:144-153.
24. Lafon M. Rabies virus receptors. J Neurovirol 2005, 11:82-87.
25. Matrai J., Chuah M.K., VandenDriessche T. Recent advances in lentiviral vector development and applications. Mol Ther 2010, 18:477-490.
26. Mazarakis N.D., Azzouz M., Rohll J.B., Ellard F.M., Wilkes F.J., Olsen A.L., et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 2001, 10:2109-2121.
27. McIver S.R., Lee C.S., Lee J.M., Green S.H., Sands M.S., Snider B.J., et al. Lentiviral transduction of murine oligodendrocytes in vivo. J Neurosci Res 2005, 82:397-403.
28. Mentis G.Z., Gravell M., Hamilton R., Shneider N.A., O'Donovan M.J., Schubert M. Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins. J Neurosci Methods 2006, 157:208-217.
29. Naciff J.M., Behbehani M.M., Misawa H., Dedman J.R. Identification and transgenic analysis of a murine promoter that targets cholinergic neuron expression. J Neurochem 1999, 72:17-28.
30. Nakano T., Windrem M., Zappavigna V., Goldman S.A. Identification of a conserved 125 base-pair Hb9 enhancer that specifies gene expression to spinal motor neurons. Dev Biol 2005, 283:474-485.
31. Reyes N.A., Fisher J.K., Austgen K., VandenBerg S., Huang E.J., Oakes S.A. Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis. J Clin Invest 2010, 120:3673-3679.
32. Shneider N.A., Brown M.N., Smith C.A., Pickel J., Alvarez F.J. Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival. Neural Dev 2009, 4:42.
33. Thiel G., Lietz M., Bach K., Guethlein L., Cibelli G. Biological activity of mammalian transcriptional repressors. Biol Chem 2001, 382:891-902.
34. Tortarolo M., Crossthwaite A.J., Conforti L., Spencer J.P., Williams R.J., Bendotti C., et al. Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress. J Neurochem 2004, 88:481-493.
35. Tortarolo M., Veglianese P., Calvaresi N., Botturi A., Rossi C., Giorgini A., et al. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci 2003, 23:180-192.
36. Vilar J.M., Saiz L. DNA looping in gene regulation: from the assembly of macromolecular complexes to the control of transcriptional noise. Curr Opin Genet Dev 2005, 15:136-144.
37. Watson D.J., Kobinger G.P., Passini M.A., Wilson J.M., Wolfe J.H. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther 2002, 5:528-537.
38. Wilson J.M., Hartley R., Maxwell D.J., Todd A.J., Lieberam I., Kaltschmidt J.A., et al. Conditional rhythmicity of ventral spinal interneurons defined by expression of the Hb9 homeodomain protein. J Neurosci 2005, 25:5710-5719.
39. Zhang Y., Zheng Y., Zhang Y.P., Shields L.B., Hu X., Yu P., et al. Enhanced adenoviral gene delivery to motor and dorsal root ganglion neurons following injection into demyelinated peripheral nerves. J Neurosci Res 2010, 88:2374-2384.
40. Zhao C., Strappe P.M., Lever A.M., Franklin R.J. Lentiviral vectors for gene delivery to normal and demyelinated white matter. Glia 2003, 42:59-67.